It is not by garbling and mutilating passages that the ideas of an author are to be learned, but by reading the context; then the meaning may be judged.
-Jean Paul Marat, speech in his own defense, 1793
We all know the stereotype: the orthopaedic surgeon who stares quizzically at a stethoscope, acknowledging that it looks vaguely familiar, although he (remember we're talking stereotypes here) can't quite recall what to do with it. Or, discovering that the stethoscope can be used to evaluate fracture healing, he decides it isn't as useless a device as he had previously thought. Or finally, if he does use it outside the musculoskeletal system, he applies it to the ''orthopaedic auscultation point'': that place just below the xyphoid where he can efficiently hear the heart, lungs, and bowel sounds simultaneously, then move quickly on to the important parts of the physical examination.
At best, stereotypes are a gross exaggeration of reality and, at worst, mean-spirited fabrications designed to reinforce prejudice. However, there may be a kernel of truth in this one. After all, if we really loved tracking down obscure tropical diseases or exploring the mysteries of cardiovascular physiology, we would have pursued different careers. The only time I lost weight during my surgical internship was the month I spent on the internal medicine service. I remember feeling convinced that the primary motivation for including that rotation in our training was to remind us why we wanted to be surgeons. I must also confess that during my years as a busy orthopaedic resident, I didn't complain when the stereotype meant that medical consultants would swoop in to take over a patient's general care in order to save the poor soul from us ignorant bone-crunchers.
However, there's a reason that orthopaedic surgeons must attend medical school. Those of us who are team physicians know that we may be the clinician of first resort when one of our athletes suddenly develops abdominal pain, passes out, or is poked in the eye. Even within our orthopaedic domain, general medicine plays an indispensable role. Although we like to concentrate on devising evermore ingenious ways to restore the human musculoskeletal system, we can never lose sight of its relationship to the functioning of the entire organism.
One striking demonstration of this truth is our collective difficulty in reliably compelling disrupted rotator cuff tendons to heal. Improvements in fixation and adjustments to the rehabilitation program may get us closer to the goal, but unfavorable biology continues to block us from hitting the back of the net consistently. Although we are aware that biological conditions at the injury site are a nemesis to healing, ongoing research seems to indicate that manifestations of a systemic diathesis or illness may also play a part. A study in this month's American Journal of Sports Medicine, for example, explores the effect that hyperlipidemia, and its treatment with statin drugs, may have on rotator cuff healing. 5 The current study builds on a foundation of prior laboratory and clinical research, harking back to 20th century investigations into the effects of nonsteroidal antiinflammatory drugs on the healing of ligaments and tendons. In 1988, Dahners and colleagues 10 published their findings that short-term administration of piroxicam increased the early strength of healing medial collateral ligaments in a rat model. Because this group subsequently found that celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, had a deleterious effect on ligament healing, 12 they thought that an experimental COX-1 inhibitor might enhance it. Unfortunately, this was not the case. 4 A subsequent study of Achilles tendon healing suggested that the timing of anti-inflammatory drug administration might be crucial. 19 Virchenko et al 19 reported that parecoxib, a COX-2 inhibitor, weakened healing of a transected tendon when given for the first 5 days after an experimental injury but strengthened it when given 6 to 14 days after injury.
More recently, Cohen and colleagues 8 extended this line of research to the rotator cuff. They surgically detached and then immediately repaired the supraspinatus tendons of rats, and then treated them with either indomethacin, a nonselective nonsteroidal anti-inflammatory drug, or the selective COX-2 inhibitor celecoxib, for 14 days. When examined 4 and 8 weeks after the original repair, both experimental groups of tendons demonstrated lower failure loads and less mature collagen organization compared with controls.
The relevance of these studies to statin use is illustrated in the 2014 publication of Dolkart et al. 11 These researchers reasoned that acute inflammation is beneficial in the early stage of rotator cuff tendon to bone healing, explaining why the administration of anti-inflammatory drugs during this period might have a negative effect. Statins, in contrast, stimulate COX-2 activity and the subsequent production of prostaglandins and thus might enhance early-phase healing. Ironically, some clinical reports have linked statin use to cases of tendon rupture. 3, 17 However, a 2015 study comparing 34,749 patients who were prescribed statins with 69,498 controls failed to support such an association. 9 In fact, Dolkart et al 11 did find that atorvastatin, given for the first 21 days after repair, enhanced stiffness and load to failure of the healing rat rotator cuff, as measured at the end of that period. In subsequent in vitro experiments, the investigators found that atorvastatin promoted the proliferation and healing behavior of both rat and human tenocytes. Further analysis suggested that atorvastatin acted by stimulating production of prostaglandin E2.
If statins aid the early stages of rotator cuff healing, it is logical to wonder whether hypercholesterolemia may adversely influence that process. In a 2014 publication, Beason et al 2 compared the healing of experimental cuff detachment and repair between rats on a normal diet and those on a high-cholesterol regimen. Despite what we might fantasize, the experimental diet consisted not of double cheeseburgers or juicy lamb chops but rather specially prepared rat chow previously shown to raise total serum cholesterol levels. Postmortem biomechanical testing revealed reduced construct stiffness in the hypercholesterolemic rats after 4 weeks but no difference at 8 weeks after repair.
Chung and colleagues 7 took this line of experimentation one step further in a rabbit study that included 2 groups of animals that were fed a high-cholesterol diet: One group continued the diet after rotator cuff repair, while the other was started on a statin drug and switched to a normal diet at the time of surgery. Subsequent biomechanical testing and histological examination of the tendon-bone interface demonstrated harmful effects of the high-cholesterol diet that were halted or reversed in the rats that reverted to a normal diet and took the statin. Undesirable effects were not limited to the tendon-bone interface: Both groups of rats on the high-cholesterol diet exhibited ''fatty infiltration'' of the rotator cuff muscle 6 weeks after repair, but the fat-to-muscle ratio subsequently improved in the group treated with diet normalization and statin administration.
In light of these intriguing laboratory findings, several groups of researchers have investigated whether clinical studies would reveal similar tendencies in humans. Two relevant comparative studies of matched cohorts reported contradictory results. Abboud and Kim 1 compared the serum cholesterol and lipid profiles of 74 patients with rotator cuff tears with those of 73 individuals with other shoulder disorders and reported that several measures of hyperlipidemia were higher in the presence of rotator cuff tears; 63% of rotator cuff patients had hypercholesterolemia compared with only 28% of the comparison group. In contrast, Longo et al 16 compared 120 patients undergoing rotator cuff repair with 120 age-and sex-matched meniscectomy patients and found no difference in serum triglycerides or total cholesterol. One possible explanation for these variable results, besides the subject selection process itself, might be the relatively low power obtained from the size of the matched groups. Two more recent studies, including the one in this month's issue, used data sources from much larger populations. Lin et al 15 examined 498,678 individuals, including 25,621 with hyperlipidemia, from a Taiwanese insurance database over an 11-year period. The investigators reported that subjects with hyperlipidemia were twice as likely to develop rotator cuff tears as those with normal lipid profiles. Multivariate analysis that accounted for other predisposing factors reduced the hazard ratio attributable to hyperlipidemia from 2.00 to 1.48. Further analysis showed that the hazard ratio was only mildly increased at 1.16 in hyperlipidemic individuals who were prescribed statins, compared with 2.01 in untreated hyperlipidemic people.
Genetics and dietary habits may vary widely among different geographic locations. The study in this month's AJSM used a large insurance database from the United States. In contrast to the Taiwanese study, Cancienne et al 5 analyzed the records of 30,638 patients who all had arthroscopic rotator cuff repairs to see whether their serum lipid status was associated with the success or failure of the surgery. The authors report that the odds of revision were increased to 1.20 in those with moderately elevated total cholesterol and 1.36 in those with high total cholesterol levels. As in the study of Lin et al, the prescription of statins seemed to have a beneficial effect, significantly reducing the rate of revision surgery. Similar results were obtained when the subjects were grouped by their serum levels of low-density lipoproteins (LDL), but not triglycerides.
Large database studies have inherent strengths and weaknesses. The size of the population studied allowed the authors to detect relatively small differences and to account for the effects of many potentially confounding variables that may also be associated with failure of a rotator cuff repair. However, the authors could identify failure only in subjects who underwent revision surgery and could determine only whether statins were prescribed, not whether they were actually consumed. It remains unknown whether more precise documentation of all healing failures and of compliance with the statin prescriptions would have strengthened or weakened the magnitude of the associations.
To put their findings into perspective, Cancienne et al calculated that the absolute risk reduction apparently attributable to statin treatment for hyperlipidemia ranged from 0.24% to 1.89%, so that the number of patients who would need to be treated to reduce the number of revisions by 1 patient ranged from 54 to 408 for total cholesterol and 53 to 387 for LDL. Although this effect is small, if I ever personally need a rotator cuff repair, I plan to avoid consuming cholesterol-enriched rat chow until my shoulder is fully healed. At the least, this research seems to provide one more reason for patients with hyperlipidemia to comply with prescribed treatment.
Hyperlipidemia and its treatment with statin drugs are just two of a great number of systemic factors that seem to influence the fate of the rotator cuff. In their large observational study, Lin et al 15 reported that the presence of diabetes also increased the risk of a rotator cuff tear occurring. Other systemic factors that have been linked by various researchers to the occurrence of cuff tears or their chances of healing include smoking, 20 gout, 13 osteoporosis, 6 genetic variation, 14 sex, 15, 20 and age. 15, 18 A guiding principle of good medical practice is never to formulate a treatment plan for an injury or disease without taking the medical, psychological, and social features of each patient into consideration. Viewing a rotator cuff tear within the context of the person in whom the shoulder resides will illuminate new pathways to promote successful surgical outcomes. Although we may count ourselves blessed to have chosen a career full of the fascinating technical challenges unique to orthopaedic surgery, our knowledge of human physiology and systemic disease processes
